Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Quercetin and Its Nano-Scale Delivery Systems in Prostate Cancer Therapy: Paving the Way for Cancer Elimination and Reversing Chemoresistance
Yaseen Hussain, Sepideh Mirzaei, Milad Ashrafizadeh, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1602-1602
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

NF‐κB as a regulator of cancer metastasis and therapy response: A focus on epithelial–mesenchymal transition
Sepideh Mirzaei, Sam Saghari, Farzaneh Bassiri, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 7, pp. 2770-2795
Closed Access | Times Cited: 150
Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression
Milad Ashrafizadeh, Sepideh Mirzaei, Mohammad Gholami, et al.
Carbohydrate Polymers (2021) Vol. 272, pp. 118491-118491
Open Access | Times Cited: 137
Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer
Sepideh Mirzaei, Mohammad Gholami, Amirhossein Zabolian, et al.
Pharmacological Research (2021) Vol. 171, pp. 105759-105759
Closed Access | Times Cited: 136
Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects
Sepideh Mirzaei, Mohammad Gholami, Farid Hashemi, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 2, pp. 436-455
Open Access | Times Cited: 132
Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Elena Okina, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 124
Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches
Milad Ashrafizadeh, Masoud Delfi, Ali Zarrabi, et al.
Journal of Controlled Release (2022) Vol. 351, pp. 50-80
Open Access | Times Cited: 124
STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response
Mehrdokht Sadrkhanloo, Maliheh Entezari, Sima Orouei, et al.
Pharmacological Research (2022) Vol. 182, pp. 106311-106311
Closed Access | Times Cited: 110
(Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapy
Milad Ashrafizadeh, Ali Zarrabi, Ashkan Bigham, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 6, pp. 2115-2176
Closed Access | Times Cited: 95
A critical review on quercetin bioflavonoid and its derivatives: Scope, synthesis, and biological applications with future prospects
Udaya Rajesh R, D. Sangeetha
Arabian Journal of Chemistry (2023) Vol. 16, Iss. 8, pp. 104881-104881
Open Access | Times Cited: 41
Exosomes as Promising Nanostructures in Diabetes Mellitus: From Insulin Sensitivity to Ameliorating Diabetic Complications
Milad Ashrafizadeh, Alan Prem Kumar, Amir Reza Aref, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 1229-1253
Open Access | Times Cited: 60
Nanotechnological Approaches in Prostate Cancer Therapy: Integration of engineering and biology
Milad Ashrafizadeh, Shahin Aghamiri, Shing Cheng Tan, et al.
Nano Today (2022) Vol. 45, pp. 101532-101532
Open Access | Times Cited: 60
Targeting PI3K/Akt signaling in prostate cancer therapy
Mehrdad Hashemi, Afshin Taheriazam, Padideh Daneii, et al.
Journal of Cell Communication and Signaling (2022) Vol. 17, Iss. 3, pp. 423-443
Open Access | Times Cited: 45
Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action
Mitra Behroozaghdam, Maryam Dehghani, Amirhossein Zabolian, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 11
Closed Access | Times Cited: 40
STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functions
Mehrdokht Sadrkhanloo, Mahshid Deldar Abad Paskeh, Mehrdad Hashemi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114168-114168
Open Access | Times Cited: 28
Therapeutic potentials and targeting strategies of quercetin on cancer cells: Challenges and future prospects
Udaya Rajesh R, D. Sangeetha
Phytomedicine (2024) Vol. 133, pp. 155902-155902
Closed Access | Times Cited: 9
Molecular signaling of prostate cancer chemoprevention by natural products: current perspectives and future directions
Satyajit Halder, Goutam Brahmachari, Kuladip Jana
Elsevier eBooks (2025), pp. 9-35
Closed Access | Times Cited: 1
Application of Nano Drug Delivery System (NDDS) in Cancer Therapy: A Perspective
Junyu Liu, Shuqin Li, Jia Wang, et al.
Recent Patents on Anti-Cancer Drug Discovery (2022) Vol. 18, Iss. 2, pp. 125-132
Closed Access | Times Cited: 36
Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges
Zhenyu Nie, Mei Chen, Yuanhui Gao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 35
Nanodelivery of Dietary Polyphenols for Therapeutic Applications
Mithun Rudrapal, Ashwini Kumar Mishra, Laxmi Rani, et al.
Molecules (2022) Vol. 27, Iss. 24, pp. 8706-8706
Open Access | Times Cited: 31
Targeting AMPK signaling in ischemic/reperfusion injury: From molecular mechanism to pharmacological interventions
Mahshid Deldar Abad Paskeh, Ava Asadi, Sepideh Mirzaei, et al.
Cellular Signalling (2022) Vol. 94, pp. 110323-110323
Closed Access | Times Cited: 30
Chinese herbal medicines for prostate cancer therapy: From experimental research to clinical practice
Fanming Kong, Chaoran Wang, Jing Zhang, et al.
Chinese Herbal Medicines (2023) Vol. 15, Iss. 4, pp. 485-495
Open Access | Times Cited: 20
Anti-cancer properties of quercetin in osteosarcoma
Parisa Maleki Dana, Fatemeh Sadoughi, Zatollah Asemi, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 34
Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies
Mahshid Deldar Abad Paskeh, Shafagh Asadi, Amirhossein Zabolian, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11669-11669
Open Access | Times Cited: 34
Immunomodulatory Effects of a Concoction of Natural Bioactive Compounds—Mechanistic Insights
Vani Gangwar, Amar K. Garg, Karan Lomore, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1522-1522
Open Access | Times Cited: 34
Natural Products for the Management of Castration-Resistant Prostate Cancer: Special Focus on Nanoparticles Based Studies
Rajeev K. Singla, Siva Sai Chandragiri, Hitesh Chopra, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top